Advertisement · 728 × 90
#
Hashtag
#TNDM
Advertisement · 728 × 90
Preview
Tandem Mobi Now Compatible with Android Smartphones Tandem Diabetes Care (Nasdaq: TNDM) announced that the Tandem Mobi automated insulin delivery system now pairs with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. The Android app received FDA clearance in November 2025 and had a limited release in December 2025.The app is available on Google Play for compatible devices, including Google Pixel 6–10 and Samsung Galaxy S21–S25, expanding patient choice and connected-care accessibility.

#TNDM Tandem Mobi Now Compatible with Android Smartphones

www.stocktitan.net/news/TNDM/tandem-mobi-no...

0 0 0 0

BREAKING NEWS: ( NASDAQ: #TNDM ) Why Tandem Diabetes Care Stock Popped Today

1 0 0 0

Breaking News: ( NASDAQ: #TNDM ) TNDM Price Target Alert: $22.00. Issued by Mizuho Securities

0 0 0 0

Just In: ( NASDAQ: #TNDM ) Neutral Recommendation Issued On TNDM By UBS

1 0 0 0
Preview
Rosen Law Firm Investigates Tandem Diabetes Care for Investor Claims After Stock Drop Rosen Law Firm opens an investigation into Tandem Diabetes Care, Inc. following allegations of misleading business communications impacting shares.

Rosen Law Firm Investigates Tandem Diabetes Care for Investor Claims After Stock Drop #United_States #New_York #Rosen_Law_Firm #Tandem_Diabetes_Care #TNDM

0 0 0 0
Preview
A diabetes tech firm's 2025 report is coming—here's when to listen Tandem Diabetes Care will post Q4 and full-year 2025 results on Feb. 19, followed by a 4:30 pm ET call and webcast available in its Investor Center.

#TNDM Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

www.stocktitan.net/news/TNDM/tandem-diabete...

0 0 0 0
Preview
Rosen Law Firm Urges Investors of Tandem Diabetes Care to Investigate Class Action Suit Rosen Law Firm is looking into potential securities claims for investors of Tandem Diabetes Care, Inc., urging action after serious allegations of misleading information.

Rosen Law Firm Urges Investors of Tandem Diabetes Care to Investigate Class Action Suit #USA #New_York #Rosen_Law_Firm #TNDM #Tandem_Diabetes

0 0 0 0
Preview
Rosen Law Firm Investigates Securities Claims for Tandem Diabetes Care Investors Amid Potential Misleading Information Rosen Law Firm is urging investors of Tandem Diabetes Care to explore a class action investigation regarding possibly misleading information that affected TNDM stock.

Rosen Law Firm Investigates Securities Claims for Tandem Diabetes Care Investors Amid Potential Misleading Information #United_States #New_York #Rosen_Law_Firm #TNDM #Tandem_Diabetes

0 0 0 0
Preview
Tandem t:slim Mobile App Now Available in Canada Tandem Diabetes Care (Nasdaq: TNDM) announced on December 18, 2025 that the Tandem t:slim mobile app is now available in Canada for Android and iOS. The app lets eligible t:slim X2 users (pump version 7.8.1+) deliver and cancel boluses from a paired smartphone, view 24-hour glucose trends, pump status, basal/bolus deliveries and suspensions, and receive pump alerts. Data can be uploaded wirelessly to the cloud-based Tandem Source platform. The t:slim X2 pump continues to operate independently, and uploads are not real-time.

#TNDM Tandem t:slim Mobile App Now Available in Canada

www.stocktitan.net/news/TNDM/tandem-t-slim-...

0 0 0 0
Preview
Investor Alert: Rosen Law Investigates Tandem Diabetes Care Class Action Claims Rosen Law Firm investigates potential class action claims against Tandem Diabetes Care. Investors may be entitled to compensation.

Investor Alert: Rosen Law Investigates Tandem Diabetes Care Class Action Claims #New_York #Rosen_Law_Firm #TNDM #Tandem_Diabetes

0 0 0 0
Preview
Rosen Law Firm Investigates Tandem Diabetes Care Investors' Claims Over Misleading Information Rosen Law Firm is investigating potential securities claims for Tandem Diabetes Care investors. Learn about the basis and how to take action.

Rosen Law Firm Investigates Tandem Diabetes Care Investors' Claims Over Misleading Information #United_States #New_York #Rosen_Law_Firm #TNDM #Tandem_Diabetes

0 0 0 0
Preview
Rosen Law Firm Investigates Securities Class Action for Tandem Diabetes Care Investors Amid Misleading Claims Rosen Law Firm is investigating potential securities claims for Tandem Diabetes Care, Inc. investors due to misleading information. Learn more about your rights.

Rosen Law Firm Investigates Securities Class Action for Tandem Diabetes Care Investors Amid Misleading Claims #USA #New_York #Rosen_Law_Firm #TNDM #Tandem_Diabetes

0 0 0 0
Preview
Rosen Law Firm Encourages Investors of Tandem Diabetes Care to Look Into Securities Class Action Investigation The Rosen Law Firm is actively investigating securities claims for investors of Tandem Diabetes Care due to misleading business information affecting stock value.

Rosen Law Firm Encourages Investors of Tandem Diabetes Care to Look Into Securities Class Action Investigation #USA #New_York #Rosen_Law_Firm #Tandem_Diabetes_Care #TNDM

0 0 0 0
Preview
Rosen Law Firm Investigates Tandem Diabetes Care for Potential Securities Misconduct Rosen Law Firm is probing alleged securities violations by Tandem Diabetes Care, encouraging investors to join a potential class action lawsuit.

Rosen Law Firm Investigates Tandem Diabetes Care for Potential Securities Misconduct #USA #New_York #Rosen_Law_Firm #TNDM #Tandem_Diabetes

0 0 0 0
Preview
Rosen Law Firm Investigates Tandem Diabetes Care for Potential Securities Fraud The Rosen Law Firm is investigating potential securities claims against Tandem Diabetes Care and encourages investors to inquire about possible compensation.

Rosen Law Firm Investigates Tandem Diabetes Care for Potential Securities Fraud #USA #New_York #Rosen_Law_Firm #Tandem_Diabetes_Care #TNDM

0 0 0 0
Preview
Tandem Mobi Receives FDA Clearance for Use with Android Smartphones Tandem Diabetes Care (Nasdaq: TNDM) announced FDA clearance of the Android version of the Tandem Mobi mobile app, expanding compatibility to Android smartphones and extending its connected-care ecosystem.Key facts: the app pairs with the Tandem Mobi automated insulin delivery system powered by Control-IQ+, cites outcomes including 79% time in range and 90% overnight time in range, and will begin a limited release in December 2025 with commercial availability in early 2026. Compatible devices slated to include Google Pixel 6–10 and Samsung Galaxy S21–S25; a full compatibility list will be published before launch.

#TNDM Tandem Mobi Receives FDA Clearance for Use with Android Smartphones

www.stocktitan.net/news/TNDM/tandem-mobi-re...

0 0 0 0
Preview
Rosen Law Firm Investigates Tandem Diabetes Care for Potential Securities Class Action Rosen Law Firm is investigating claims regarding Tandem Diabetes Care, potentially misrepresenting business information to investors, impacting stock prices significantly.

Rosen Law Firm Investigates Tandem Diabetes Care for Potential Securities Class Action #United_States #New_York #Rosen_Law_Firm #Tandem_Diabetes_Care #TNDM

0 0 0 0

#TNDM Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards

www.stocktitan.net/news/TNDM/tandem-diabete...

0 0 0 0
Preview
Pomerantz Investigates Tandem Diabetes Care for Investor Protection Amid Claims of Malfunction Pomerantz LLP is delving into allegations concerning Tandem Diabetes Care, focusing on potential securities fraud linked to insulin pump malfunctions.

Pomerantz Investigates Tandem Diabetes Care for Investor Protection Amid Claims of Malfunction #USA #New_York #Pomerantz_LLP #Tandem_Diabetes_Care #TNDM

0 0 0 0
Preview
Rosen Law Firm Investigates Tandem Diabetes Care for Shareholder Claims After Press Release Rosen Law Firm is probing potential claims for investors of Tandem Diabetes Care, following allegations of misleading business information that may have impacted their stock.

Rosen Law Firm Investigates Tandem Diabetes Care for Shareholder Claims After Press Release #USA #New_York #Rosen_Law_Firm #TNDM #Tandem_Diabetes

0 0 0 0
Preview
Investors Face Concerns as Pomerantz Law Firm Investigates Tandem Diabetes Care, Inc. for Potential Misconduct Pomerantz LLP is looking into allegations of securities fraud involving Tandem Diabetes Care, Inc., following a serious malfunction in insulin pumps that affected investors significantly.

Investors Face Concerns as Pomerantz Law Firm Investigates Tandem Diabetes Care, Inc. for Potential Misconduct #United_States #New_York #Pomerantz_LLP #TNDM #Tandem_Diabetes

0 0 0 0
Preview
Investigation Alert: Tandem Diabetes Care, Inc. Faces Fraud Claims from Shareholders Tandem Diabetes Care, Inc. is embroiled in a potential fraud investigation led by the Schall Law Firm after a malfunction in insulin pumps was reported. Investors are urged to take action.

Investigation Alert: Tandem Diabetes Care, Inc. Faces Fraud Claims from Shareholders #USA #Los_Angeles #Schall_Law_Firm #Tandem_Diabetes_Care #TNDM

0 0 0 0
Preview
Investigation into Tandem Diabetes Care: Potential Securities Fraud Claims Emerged Pomerantz Law Firm is probing potential securities fraud claims involving Tandem Diabetes Care, following alarming issues with their insulin pumps.

Investigation into Tandem Diabetes Care: Potential Securities Fraud Claims Emerged #United_States #New_York #Pomerantz_LLP #Tandem_Diabetes_Care #TNDM

0 0 0 0
Preview
Rosen Law Firm Investigates Tandem Diabetes Care Investor Claims Amid Stock Drop Rosen Law Firm is investigating claims for Tandem Diabetes Care investors following significant stock declines. The firm encourages participation in potential class action.

Rosen Law Firm Investigates Tandem Diabetes Care Investor Claims Amid Stock Drop #United_States #New_York #Rosen_Law_Firm #Tandem_Diabetes_Care #TNDM

0 0 0 0
Preview
Investors Alert: Pomerantz Law Firm Probes Tandem Diabetes Care, Inc. Claims Pomerantz LLP investigates potential securities fraud at Tandem Diabetes Care, Inc. following a malfunction in insulin pumps that may endanger patient health.

Investors Alert: Pomerantz Law Firm Probes Tandem Diabetes Care, Inc. Claims #United_States #New_York #Pomerantz_Law #Tandem_Diabetes_Care #TNDM

0 0 0 0
Preview
Pomerantz Law Firm Investigates Potential Claims Against Tandem Diabetes Care, Inc. Pomerantz LLP is probing claims for investors in Tandem Diabetes Care, Inc. following revelations of a serious malfunction in insulin pumps impacting user safety.

Pomerantz Law Firm Investigates Potential Claims Against Tandem Diabetes Care, Inc. #United_States #New_York #Pomerantz_LLP #Tandem_Diabetes_Care #TNDM

0 0 0 0
Preview
First-Ever Smartphone Insulin Bolus Control: Tandem's t:slim App Cleared in Canada for Diabetes Care Tandem's mobile app enables smartphone bolus delivery and cloud data upload for t:slim X2 pump users. Features 24-hour glucose tracking and insulin therapy monitoring. Launch expected late 2025.

#TNDM Tandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android Phones

www.stocktitan.net/news/TNDM/tandem-t-slim-...

0 0 0 0

News; ( NASDAQ: #TNDM ) TNDM Price Target Alert: $24.00. Issued by Canaccord Genuity

0 0 0 0